Literature DB >> 8640549

Pyrazinamide--on the antituberculosis drug frontline.

D A Mitchison1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8640549     DOI： 10.1038/nm0696-635

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.

Authors:  Diane J Ordway; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Daniel S Bucy; Laurel Hascall-Dove; Marcela Henao-Tamayo; Marisa R Harton; Shaobin Shang; David Ackart; Susan L Kraft; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

2.  A Computational Study of Cytotoxicity of Substituted Amides of Pyrazine- 2-carboxylic acids Using QSAR and DFT Based Molecular Surface Electrostatic Potential.

Authors:  Sharieh Hosseini; Majid Monajjemi; Elahe Rajaeian; Mohammad Haghgu; Aliakbar Salari; Mohammad Reza Gholami
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

3.  Modulating the Global Response Regulator, LuxO of V. cholerae Quorum Sensing System Using a Pyrazine Dicarboxylic Acid Derivative (PDCApy): An Antivirulence Approach.

Authors:  M Hema; Sahana Vasudevan; P Balamurugan; S Adline Princy
Journal:  Front Cell Infect Microbiol       Date:  2017-10-12       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.